medline.ch Onkologie Urologische Tumoren

	Metabolomic profiling of renal cell carcinoma to identify prognostic markers of metastasis. PLoS One Williams M, Chakraborty A, Main B, Li L, Chan YC, Wang X, Verbeeck N, Spiers L, Routten O, Chin T, Bejar K, Troyer D. PMID: 43013589 [PubMed - indexed for MEDLINE]
	Circulating Tumor DNA in Oligoprogressive Prostate Cancer Treated With Stereotactic Radiotherapy: A Prespecified Secondary Analysis of a Nonrandomized Clinical Trial. JAMA Netw Open Reid A, Tran A, Thakali S, Wetterskog D, Orlando F, Wingate A, Patel P, Cole A, Frew J, Mullassery V, van As N, Suh YE, Demichelis F, Tree A, Attard G. PMID: 43013307 [PubMed - indexed for MEDLINE]
	Long-term outcomes of radical prostatectomy versus radiation therapy for high- and very high-risk localized prostate cancer: an IPTW analysis from a multicenter Asian database. Int Urol Nephrol Chu CW, Liu HY, Chang YL, Liu YY, Wang HJ, Chen YT, Cheng YT, Kang CH, Tee WQ, Yu TY, Lee IW, Luo HL. PMID: 43013243 [PubMed - as supplied by publisher]
	Real-world performance of pelvic MRI and abdominopelvic CT for nodal staging in higher-risk prostate cancer and the incremental clinical value of CT. World J Urol Merani U, Arcuri O, Calleris G, Sasia A, Dematteis A, Venturi A, Marquis A, Gatti M, Grimaldi S, Rovera G, Morbelli S, Oderda M, Gontero P, Marra G. PMID: 43013110 [PubMed - indexed for MEDLINE]
	Machine Learning Applications in Prostate Cancer Genomics: From Mutation Signatures to Clinical Prediction Models. Res Rep Urol Coman RA, Elec FI, Iancu DM, Guven S, Tokas T, Juliebø-Jones P, Tzelves L, Somani BK. PMID: 43011873 [PubMed]
	Extracellular vesicles as integrative hubs of drug resistance in bladder cancer. Cancer Drug Resist Huang CS, Yu CP, Yu DS, Wu YS, Jiang SS, Zhao R, Lee DF, Ho JY. PMID: 43011771 [PubMed]
	Bladder cancer immune microenvironment: immune-cell distribution, disease associations, treatment remodeling, and baseline immune features associated with treatment response and prognosis. Front Oncol Qin S, Yu X, Zuo S, He X, Liu J. PMID: 43011329 [PubMed]
	C-reactive protein-albumin-lymphocyte index and survival outcomes in renal cell carcinoma: a systematic review and meta-analysis. Front Oncol Wei Y, Mai L, Zhang X, Zhang Y, Lin Y. PMID: 43011006 [PubMed]
	Development and validation of a machine learning-based model for predicting survival in patients with bladder neuroendocrine carcinoma: a large retrospective study. Front Oncol Qi S, Dong W, Shi Z, Sun Y, Zhang D, Liu C, Li H, Hu L. PMID: 43010898 [PubMed]
	A DNA Nanoplatform with Rolling Circle-DNAzyme Feedback Programming for Autonomous Exponential Amplification Enables Multiplexed Orthogonal miRNA Profiling toward Precise Diagnosis of Bladder Cancer. Anal Chem Yang M, Chen H, Mao H, Ye X, Fan H, Sheng Y, Zhang Y. PMID: 43010419 [PubMed - indexed for MEDLINE]
	Does imaging-based clinical staging improve the predictive performance of the CAPRA score? BMC Urol Iplikci A, Canpolat HE, Gunduz N, Cakici MC, Yildirim A. PMID: 43009921 [PubMed - indexed for MEDLINE]
	Geometry based gene-expression signatures detect cancer treatment responders in clinical trials. BMC Cancer Chachólski W, Ramanujam R. PMID: 43009859 [PubMed - indexed for MEDLINE]
	Tumor-derived microRNAs as early predictive biomarkers for toxicity induced by immunotherapy in urothelial cancer. J Cancer Res Clin Oncol Gaibar M, Romero-Lorca A, Rodríguez-Piñas JM, Rubio M, Pérez-Ortiz JM, Malón D, Hernando S, Alemany I, Camacho FI, Cavanagh M, Gómez P, Marrupe D, Martín AM, Khedaoui R, Fernández-Santander A, Novillo A. PMID: 43009659 [PubMed - indexed for MEDLINE]
	Prospective and genetic analyses implicate lower immunosurveillance in the aetiology of prostate cancer. Nat Commun Parsaeian M, Chan WC, Atkins JR, Papier K, Breeur M, Desai TA, Huang Z, Ogamba CF, Conti DV, Bogumil D, Shen J, Sim MJW, Tsilidis KK, Yarmolinsky J, Rinaldi S, Kaaks R, Katzke V, Schulze MB, Schiborn C, Caini S, Milani L, Zamora-Ros R, Guevara M, Sánchez MJ, Chirlaque MD, Amiano P, PRACTICAL Consortium, Elliott T, Mills IG, Riboli E, Le Marchand L, Haiman C, Key TJ, Smith-Byrne K, Travis RC. PMID: 43009480 [PubMed - indexed for MEDLINE]
	Spatial transcriptomics tumor microenvironment determinants of tyrosine kinase inhibitor response in renal cell carcinoma: results from a phase 2 clinical trial. Signal Transduct Target Ther Hasanov E, Ali MIH, Deshmukh S, Ovando-Ricardez JA, Lam T, Hoang A, Liu XD, Wang X, Peterson CB, Xiao L, Matin SF, Sircar K, Tannir NM, Hasanov M, Jonasch E. PMID: 43009462 [PubMed - indexed for MEDLINE]
	Nanoparticle delivery of phytochemicals and dietary factors for epigenetic modulation in prostate cancer. Urol Oncol Malik A, Ravinuthala RP, Jha AK. PMID: 43009428 [PubMed - as supplied by publisher]
	PARP inhibitor-based combinations in first-line metastatic castration-resistant prostate cancer: A meta-analysis. Urol Oncol Ben Kridis W, Khanfir A. PMID: 43009426 [PubMed - as supplied by publisher]
	Quality-of-life Outcomes and Patient-reported Outcome Measures After Penile-preserving Surgery to Treat Penile Cancer: A Systematic Review and Meta-analysis. Eur Urol Focus Chall K, Komperla S, Seeruthun R, Hayre S, Alnajjar HM, Pang KH, Muneer A. PMID: 43009388 [PubMed - as supplied by publisher]
	Prognostic Relevance of Soluble B7-H3/CD276 in Prostate Cancer Patients With Bone Metastases. Clin Genitourin Cancer Zhang L, Liu Y, Liu A, Yin Q, Gong H. PMID: 43009346 [PubMed - as supplied by publisher]
	Radical and Partial Nephrectomy: Complications. Urol Clin North Am Wang SL, Alkhatib KY, Pierorazio PM. PMID: 43009232 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 182864

Seite 1 von 9144

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung